Related Experiment Videos
Evaluation of calcium-mediated vasoconstriction in chronic congestive heart failure
Insights
Nifedipine improved hemodynamics in heart failure by reducing afterload and enhancing systemic flow. This calcium channel blocker did not cause orthostatic hypotension and showed potential for understanding vasoconstrictor mechanisms.
Area of Science:
- Cardiology
- Pharmacology
- Physiology
Background:
- Intercellular calcium in vascular smooth muscle causes vasoconstriction, increasing afterload in chronic heart failure.
- This vasoconstriction is a potential adverse mechanism in patients with severe chronic congestive heart failure.
Purpose of the Study:
- To evaluate hemodynamic, sympathetic reflex, and hormonal responses to nifedipine in patients with severe chronic congestive heart failure.
- To assess the effects of calcium channel antagonism on afterload, systemic flow, and pulmonary hypertension.
Main Methods:
- Nine patients with severe chronic congestive heart failure received a 10 mg oral dose of nifedipine.
- Hemodynamic data, sympathetic reflexes (cold pressor test), and hormonal responses (plasma renin activity, aldosterone, catecholamines) were measured.
- Supine and head-up tilt measurements were taken to assess orthostatic responses.
Main Results:
- Nifedipine primarily reduced afterload, improved systemic flow, and decreased pulmonary hypertension within 30 minutes.
- No orthostatic hypotension occurred despite reduced supine blood pressure during head-up tilt.
- Reflex sympathetic responses were improved but still attenuated; plasma renin activity increased, with a dissociated aldosterone response; plasma catecholamines remained unchanged.
Conclusions:
- Calcium antagonism with nifedipine significantly improved hemodynamics and reduced afterload in chronic congestive heart failure.
- The treatment enhanced reflex responsiveness and may influence other vasoconstrictor hormones independently of direct hemodynamic effects.
- Nifedipine offers insights into vasoconstrictor mechanisms and potential therapeutic benefits for specific heart failure patient subsets.
Abstract:
Intercellular vascular smooth muscle calcium results in vasoconstriction and is therefore a potentially adverse mechanism of increased afterload in chronic congestive heart failure. Therefore, an evaluation was made of supine and tilt hemodynamic data, sympathetic reflexes, and the hormonal response to calcium channel antagonism after administration of nifedipine in nine patients with severe chronic congestive heart failure. After a 10 mg oral dose, the peak hemodynamic response occurred at 30 minutes and was characterized primarily by afterload reduction, improvement of systemic flow, and reduction of pulmonary hypertension. Despite reduction of supine blood pressure, there was no orthostatic hypotension during head-up tilt at the same time of peak response. Reflex responses to sympathetic stimulation (cold pressor test) were improved but still attenuated when compared with normal responses. Plasma renin activity increased significantly, but a dissociation of the aldosterone response was observed. Plasma catecholamine levels were not significantly altered. In summary, calcium antagonism resulted in significant afterload reduction and hemodynamic improvement in chronic congestive heart failure. This was associated with improved reflex responsiveness and, potentially, altered other vasoconstrictor hormones independently of the hemodynamic response. Calcium antagonism may provide a means to further understand vasoconstrictor mechanisms in heart failure and enhance therapy in appropriate patient subsets.